Target intelligence / Profile preview

Integrin alpha FG-GAP repeat containing 2 pseudogene

Molecular classification
Pseudogene
01

Overview

The integrin alpha FG-GAP repeat containing 2 pseudogene (ENSG00000251627) is a pseudogene, which means it is a nonfunctional segment of DNA resembling a functional gene but is generally unable to produce any functional protein product[2][8]. Pseudogenes may arise by gene duplication or retrotransposition, and while they sometimes retain sequence similarity to their parent gene, they typically lack biological function and are not considered therapeutic targets[2]. The protein-coding gene counterpart for this pseudogene is integrin alpha FG-GAP repeat containing 2 (ITFG2), which is associated with amino acid sensing and mTORC1 signaling, but ENSG00000251627 itself does not encode a functional protein[5][8]. Essential context: Integrin alpha FG-GAP repeat containing 2 pseudogene should not be confused with the functional ITFG2 gene, which does code for a protein implicated in cell signaling pathways[3][5]. Pseudogenes can sometimes play regulatory roles or be transcribed at low levels, but the vast majority are nonfunctional and do not participate directly in disease, drug interaction, or cellular processes as proteins do[2][4]. This entry is *mistaken* as a drug target or receptor because it refers to a pseudogene, not a functioning molecular entity usable as a therapeutic target.

Other names
ITFG2P

Beyond the preview

Go deeper on Integrin alpha FG-GAP repeat containing 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrin alpha FG-GAP repeat containing 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call